Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 09 April 2021
Sec. Women's Cancer
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.639980

RETRACTED: LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway

Retracted

A retraction of this article was approved in:

  1. Retraction: LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway

    1. Read retraction
\r\nJie Zhang&#x;Jie Zhang1†Pinping Jiang&#x;Pinping Jiang2†Shoyu WangShoyu Wang3Wenjun Cheng Wenjun Cheng1*Shilong Fu Shilong Fu1*
  • 1Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • 2Department of Gynecology, Nanjing Medical University, Nanjing, China
  • 3Department of Molecular and Cellular Oncology, Nanjing University Medical School, Nanjing, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Zhang J, Jiang P, Wang S, Cheng W and Fu S (2021) LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway. Front. Oncol. 11:639980. doi: 10.3389/fonc.2021.639980

Received: 10 December 2020; Accepted: 23 February 2021;
Published: 09 April 2021; Retracted: 08 February 2022.

Edited by:

Jian-Jun Wei, Northwestern University, United States

Reviewed by:

Tamer Refaat, Loyola University Chicago, United States
Elena Gershtein, Russian Cancer Research Center NN Blokhin, Russia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.